Replies to post #13406 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

I don’t think MNTA is looking to be acquired, but the BoD would, of course, have to consider any bona fide offer.

The most likely suitors, IMO, are the Japanese Big Pharma. The buyout premiums paid for small-cap biotechs vary widely, as you can see from the table in #msg-112225824.

[dumaflotchie]

MNTA would have to divest Glatopa for such a deal to pass muster....

Why is this a give when Glatopa is not even on the market and therefore isn't anticompetitive? Furthermore, I doubt this buyout would prevent launch of Glatopa regardless since MNTA has a partner that almost certainly has right to launch.